Software AG, a German software giant with 4,300 employees, has acquired San Diego-based Zementis, a specialist in machine learning and data science. Financial terms of the deal were not disclosed, according to a statement Friday, after the acquisition closed last week. Zementis CEO Michael Zeller co-founded the company in 2004 to help customers glean new insights from … Continue reading “Germany’s Software AG Adds Analytic Tools with Zementis Buyout”
Category: San Diego
Astute Medical Receives $1,000,100 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9447ee27-4b75-4e1e-aa89-f3a9b086f6d1 Date 12/6/2016 Company Name Astute Medical Mailing Address 3550 General Atomics Court San Diego, CA 92121 USA Company Description Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers. Website http://www.astutemedical.com Transaction Type Debt Transaction Amount $1,000,100 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Astute Medical Receives $1,000,100 New Funding Round”
With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill
The U.S. Senate cleared the way for the 21st Century Cures Act, an omnibus healthcare spending and reform bill, by voting 85-13 to end debate this evening. It passed the House with 392 votes last week. After a final Senate vote as early as tomorrow, it will head to President Obama’s desk. The president used … Continue reading “With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill”
With Cowboys’ Backing, Blue Star Set to Boost Sports Startups
Dallas—Partners with a deep well of subject matter expertise and capital are on the top of any entrepreneur’s wish list. Now an accelerator tailored to sports technology startups might be giving those founders a connection to the ultimate in sports and marketing royalty: the Dallas Cowboys. The new Blue Star Accelerator, aimed at nurturing young … Continue reading “With Cowboys’ Backing, Blue Star Set to Boost Sports Startups”
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update
[Updated, 12/5/16, 4 p.m. See below.] If you’re following cancer immunotherapy, you might feel a bit swamped by this week’s wave of clinical data from experimental programs that turn living T cells into revved-up cancer fighters. We’re updating our ongoing cancer immunotherapy trial resource with American Society of Hematology results, plus a few others we’ve … Continue reading “The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update”
This Week in Drug Pricing and Post-Election Healthcare Policy News
Healthcare news has been coming fast and furious in the fallout of the election, particularly this week. Read on below for the latest on the 21st Century Cures Act, the Trump Administration’s latest nominees, and a biopharma CEO’s warning to his peers on drug pricing. IN WASHINGTON… —The House of Representatives passed a sweeping healthcare … Continue reading “This Week in Drug Pricing and Post-Election Healthcare Policy News”
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More
We’ve packed some extra stuffing into the roundup this week to account for some burnt turkey delivered by biopharma in the few days before Thanksgiving—starting with Eli Lilly’s failed gamble in Alzheimer’s disease. Lilly wasn’t alone, however. Several companies, among them Juno Therapeutics, Arrowhead Pharmaceutials, and Nivalis Therapeutics, have had some bad news for investors … Continue reading “Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More”
Connect Hands Out 10 Most Innovative New Product Awards
[Corrected 12/5/16, 9:35 am. Awards were made in 10 categories.] Connect, the San Diego nonprofit supporting local innovation and entrepreneurship, handed out its Most Innovative New Product Awards at a dinner last night in La Jolla—recognizing innovations that range from an inflatable satellite antenna to a mobile app for art museums. Volunteer entrepreneurs, investors, and … Continue reading “Connect Hands Out 10 Most Innovative New Product Awards”
An Innovation Snapshot of Medellin, Colombia
As we fly over Cuba en route from Fort Lauderdale to Medellin, I am already imbibing the upcoming culture change from the happy chaos at the departure gate in Florida. The plane is surprisingly not full and my fellow passengers, primarily Hispanics, are in a sleepy good mood. We will be arriving at 1am and … Continue reading “An Innovation Snapshot of Medellin, Colombia”
AttackIQ Garners $8,800,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c2649629-463f-468e-b3a8-e5731f38949c Date 12/2/2016 Company Name AttackIQ Mailing Address 5703 Oberlin Dr. San Diego, CA 92121 USA Company Description After more than two years working with hundreds of mid- to large-size enterprise and consulting, MSSP and VAR companies worldwide, the FireDrill platform is ready for reveal. Website http://www.attackiq.com Transaction Type Venture Equity Transaction … Continue reading “AttackIQ Garners $8,800,000 Series A Financing Round”
AttackIQ, Which Makes Tools to Assess Cybersecurity, Raises $8.8M
San Diego-based AttackIQ, a cybersecurity startup providing a Web-based platform for assessing network defenses, has finally closed its Series A round of founding, after raising a total of $8.8 million over the past three years, according to co-founder and CEO Stephan Chenette. Institutional investors included San Francisco-based Index Ventures, Qualcomm Ventures, and Telstra Ventures. In … Continue reading “AttackIQ, Which Makes Tools to Assess Cybersecurity, Raises $8.8M”
Ytel Obtains New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=df9f5da9-4f79-4bbc-bc76-441984614d18 Date 12/1/2016 Company Name Ytel Mailing Address 27422 Portola Parkway Foothill Ranch, CA 92610 USA Company Description We’re a software company with a passion to help businesses better communicate with leads, prospects, and customers. We geek out over the challenges of telecom and deliver best in class communications solutions. Website http://www.ytel.com … Continue reading “Ytel Obtains New Financing”
Solarflare Communications Garners $22,240,273 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da270b8a-de3c-4ea2-859e-68e6feb3668d Date 12/1/2016 Company Name Solarflare Communications Mailing Address 7505 Irvine Center Drive Irvine, CA 92618 USA Company Description Solarflare Communications Inc. is a leading silicon vendor delivering Ethernet products that enable the rapid adoption of 10 Gigabit for data center and enterprise networks. Our products include 10GBASE-T PHYs and high-performance Ethernet … Continue reading “Solarflare Communications Garners $22,240,273 New Funding”
TicketSauce Obtains $2,500,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0cb4cb29-9f48-4b80-beba-bf8eb8a2291a Date 12/1/2016 Company Name TicketSauce Mailing Address 12526 High Bluff Drive San Diego, CA 92130 USA Company Description Our mission is to make it possible for event organizations of all sizes and types to have their own easy-to-use Event Management Solution. Website http://www.ticketsauce.com Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction … Continue reading “TicketSauce Obtains $2,500,000 Series A Financing”
Novogene Technology Receives $75,000,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94c4096a-1d7b-4a5f-aec2-e7468ed5a827 Date 12/1/2016 Company Name Novogene Technology Mailing Address 823 Anchorage Place Chula Vista, CA 91914 USA Company Description Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world. Website http://www.novogene.com Transaction Type Venture Equity … Continue reading “Novogene Technology Receives $75,000,000 Series B Funding Round”
Brushing Aside Critics, House Votes in Landslide for Cures Act
By a 392 to 26 vote, the U.S. House of Representatives has passed the omnibus healthcare legislation called the 21st Century Cures Act, bringing new funding for top Obama administration health priorities a big step closer to the outgoing president’s signature. While critics of the bill questioned whether that funding would actually materialize in coming … Continue reading “Brushing Aside Critics, House Votes in Landslide for Cures Act”
RAM shift phase 2
[Editor’s note: Seattle-based sci-fi author Greg Bear has contemplated a day when intelligent machines, which are already assisting or replacing humans in manufacturing and transportation, could do his job, too. Indeed, a World Economic Forum study (PDF) predicts that technologies such as artificial intelligence and robotics will replace some 5 million jobs by 2020, while … Continue reading “RAM shift phase 2”
Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies
Two big pieces of the Trump healthcare puzzle have fallen into place. The President-elect’s transition team has nominated Georgia Republican congressman Tom Price to be Health and Human Services secretary. It has also tabbed Indiana health consultant Seema Verma to run the Centers for Medicare and Medicaid Services. In a statement, Rep. Fred Upton (R-MI), … Continue reading “Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies”
The Tough Questions You Must Discuss Before You Take the Money
If all goes well, the day will come when just one small thing will stand between you and funding for your startup: your signature on a term sheet. Most founders quickly sign on the line and get back to the business of growing their business. Smart ones set aside the paperwork, grab their business partners, … Continue reading “The Tough Questions You Must Discuss Before You Take the Money”
When Innovation Is Not Enough: How GreatCall Has Grown Its Market
In the 10 years since David Inns joined San Diego-based GreatCall as CEO, he has seen a proliferation of innovative healthtech startups that are targeting baby boomers who are in or nearing retirement. A lot of these digital health companies are trying to connect with senior living communities, typically at events like the annual Aging … Continue reading “When Innovation Is Not Enough: How GreatCall Has Grown Its Market”
Should We Rewrite the Human Genome?
Scientists are engineering a new living thing: a radically modified version of the lowly bacterium E. coli. In an article in Science from August, researchers at Harvard University described an ongoing project to build the genetic code of E. coli from scratch, but with major revisions to create a new strain unlike any in existence. The modified E. coli is … Continue reading “Should We Rewrite the Human Genome?”
Cybersecurity Firm Proficio Raises $12M in Private Equity Round
Proficio, a Carlsbad, CA-based startup providing cybersecurity protection services for middle market companies, has raised $12 million in an investment round led by Kayne Anderson Capital Advisors. The Los Angeles-based private equity firm provided funding from its Kayne Partners Fund Group, which invests in high-growth technology businesses. Proficio, founded in Irvine, CA, in 2010, specializes … Continue reading “Cybersecurity Firm Proficio Raises $12M in Private Equity Round”
Albert Garners $2,500,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5111fbbb-8d2f-4729-98ae-ccb486c3eb36 Date 11/24/2016 Company Name Albert Mailing Address Undisclosed Los Angeles, CA 90049 USA Company Description We built Albert on the idea that the best financial advice should be simple and jargon-free. We made it easy to take action directly from the app, and we made it free. Website http://www.meetalbert.com Transaction Type … Continue reading “Albert Garners $2,500,000 Seed Round”
Precision Medicine In Trump Era? California Presses Own Modest Program
[Updated, 11/22/16, 5:42 p.m. See below.] Among the many questions swirling around the incoming Trump administration is the fate of ambitious biomedical science projects that require federal funding. What will a Trump presidency and Republican control of Congress mean for the Precision Medicine Initiative and the Cancer Moonshot program, both championed by the Obama administration? … Continue reading “Precision Medicine In Trump Era? California Presses Own Modest Program”
The Convergence of Information Technology and the Life Sciences
We are at an incredible inflection point in the traditionally distinct fields of information technology and the life sciences. These broad disciplines are converging to advance fields of study like computational biology and systems biology, resulting in new forms of therapeutics and diagnostics that could have a monumentally positive impact on human health. At DFJ … Continue reading “The Convergence of Information Technology and the Life Sciences”
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge
Uncertainty surrounding this year’s presidential election has kept U.S. IPO activity at a sluggish pace—so sluggish, in fact, that this year could end with the fewest IPOs and the lowest level of capital raised since 2009, according to PitchBook data for the first nine months of 2016. But this is no time to trash talk … Continue reading “Sluggish Year for IPOs, But Signs Abound of Post-Election Surge”
Genalyte Garners $36,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9013aef1-443b-493a-b317-d0449ec10dd1 Date 11/22/2016 Company Name Genalyte Mailing Address 10520 Wateridge Circle San Diego, CA 92121 USA Company Description At Genalyte, Inc. Results Matter, Now. Bringing the doctor, the patient and test results together when they matter most. Website http://www.genalyte.com Transaction Type Venture Equity Transaction Amount $36,000,000 Transaction Round Undisclosed Proceeds Purposes Genalyte … Continue reading “Genalyte Garners $36,000,000 New Round”
Proficio Garners $12,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d77dce3-c28e-4add-8079-9b79e591904d Date 11/21/2016 Company Name Proficio Mailing Address 3264 Grey Hawk Court Carlsbad, CA 92010 USA Company Description Proficio is a leading Managed Security Service Provider (MSSP). We are changing the way organizations meet their IT security and compliance goals by providing the most advanced cloud-based solutions to monitor and scan critical … Continue reading “Proficio Garners $12,000,000 New Funding Round”
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More
Speculation swirled this week around the incoming U.S. president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that naming-and-shaming—that is, Congress hauling executives into hearings and penning angry letters—certainly hasn’t done the trick. For one new kind of cholesterol drug, insurers and their agents have tried … Continue reading “Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More”
Heal Receives $14,800,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dec98caa-50c5-4d8a-8dce-c724f3889207 Date 11/18/2016 Company Name Heal Mailing Address 528 Palisades Drive Pacific Palisades, CA 90272 USA Company Description Heal delivers caring, licensed and background-checked pediatricians and family doctors for primary care and urgent care house calls on-demand and on your schedule for just $99. Website http://www.getheal.com Transaction Type Venture Equity Transaction Amount … Continue reading “Heal Receives $14,800,000 Series B Financing Round”
How to Lower Drug Prices, Improve Care, and Save Pharma
I recently received a note from a longtime friend who questioned me on the issue of pharma pricing. I answered with the always-reliable alleviating-the-scourge-of-disease-through-the-miracle-of-modern-medicine defense of “free-market pricing.” My friend, who is not in the pharmaceutical business, responded: The fundamental flaw in your argument centers on the notion that there is any relevance to “market … Continue reading “How to Lower Drug Prices, Improve Care, and Save Pharma”
Astute Medical Receives $2,000,200 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bff63f91-0711-4918-a9a9-34bcf864011e Date 11/17/2016 Company Name Astute Medical Mailing Address 3550 General Atomics Court San Diego, CA 92121 USA Company Description Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers. Website http://www.astutemedical.com Transaction Type Debt Transaction Amount $2,000,200 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Astute Medical Receives $2,000,200 New Financing Round”
Mavenlink Secures $39,000,000 Series D Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7148fbbb-58d3-4f0e-8a80-90ff7a8904e7 Date 11/17/2016 Company Name Mavenlink Mailing Address 6501 Irvine Center Drive Irvine, CA 92618 USA Company Description A better way to manage your projects online with features designed to streamline workflow and increase your productivity. Website http://www.mavenlink.com Transaction Type Venture Equity Transaction Amount $39,000,000 Transaction Round Series D Proceeds Purposes This … Continue reading “Mavenlink Secures $39,000,000 Series D Funding”
Mobalytics Garners $2,600,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7539c637-f415-49e5-9847-9885c8492ccd Date 11/17/2016 Company Name Mobalytics Mailing Address 520 Broadway Santa Monica, CA 90401 USA Company Description Mobalytics is the 1st personal performance analytics for competitive League of Legends gamers. Our system uses in-game data that’s available through Riot’s API to calculate player performance and provide you with actionable advice on how … Continue reading “Mobalytics Garners $2,600,000 Seed Funding Round”
Zwift Receives $27,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1d548c72-0af2-48fe-9996-aaa2a87e7265 Date 11/17/2016 Company Name Zwift Mailing Address 301 E. Ocean Blvd. Long Beach, CA 90802 USA Company Description Zwift has big ambitions that extend well beyond the hard-core cyclists who’ve found the company on their own. Website http://www.zwift.com Transaction Type Venture Equity Transaction Amount $27,000,000 Transaction Round Series A Proceeds Purposes … Continue reading “Zwift Receives $27,000,000 Series A Financing Round”
Tragara Pharmaceuticals Secures $3,261,352 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f129952a-de29-43ec-8796-fadea8394d19 Date 11/17/2016 Company Name Tragara Pharmaceuticals Mailing Address 3152 Lionshead Avenue Carlsbad, CA 92010 USA Company Description Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. Website http://www.tragarapharma.com Transaction Type … Continue reading “Tragara Pharmaceuticals Secures $3,261,352 New Financing Round”
The New Crowdfunding Rules: Will They Really Help Startups?
Hailed as the true democratizer of private investment, crowdfunding has been attracting both headlines and a fast-growing pile of cash. In May of 2016, rules from the Securities and Exchange Commission went into effect that will democratize the process even further. These new rules will open the doors to more investors, but they also pose … Continue reading “The New Crowdfunding Rules: Will They Really Help Startups?”
Greenfly Lands $6,200,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=05427bb8-f9ec-44f1-bf27-98b905a6fcad Date 11/14/2016 Company Name Greenfly Mailing Address 604 Arizona Avenue Santa Monica, CA 90401 USA Company Description Greenfly’s technology platform transforms an organization’s existing relationship network into a new, powerful source for content creation and distribution. Website http://www.greenfly.com Transaction Type Venture Equity Transaction Amount $6,200,000 Transaction Round Series A Proceeds Purposes … Continue reading “Greenfly Lands $6,200,000 Series A Funding”
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More
The presidential election ended with Donald Trump’s stunning victory and Republican retention of the House and Senate. Now, the U.S. healthcare sector will try to figure out what it all means. Drug company stocks got a boost with the defeat of Hillary Clinton, a vocal critic of drug prices. But Trump’s plans are unclear. Will … Continue reading “Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More”
Revision Optics Garners $32,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6aa46065-5859-4ecb-bfc3-9fd024fe9f76 Date 11/11/2016 Company Name Revision Optics Mailing Address 25651 Atlantic Ocean Dr Lake Forest, CA 92630 USA Company Description The PRESBYLENS Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia. Website http://www.revisionoptics.com Transaction Type Venture Equity … Continue reading “Revision Optics Garners $32,000,000 New Round”
Trump Team Outlines Healthcare Agenda—No Mention of Drug Prices
The incoming Trump administration has posted an outline of its healthcare agenda on its transition website. There is no mention of drug pricing or what the administration might do about frequent price increases, such as Mylan’s EpiPen practice, that critics say are unsubstantiated and unethical. During the campaign, Trump’s official platform called for a change … Continue reading “Trump Team Outlines Healthcare Agenda—No Mention of Drug Prices”
Quick, How Might the Alien Spacecraft Work?
[This post is about the movie “Arrival“; there are no movie spoilers here.] “It’s an interesting script,” said someone on our PR team. It’s pretty common for us to get requests from movie-makers about showing our graphics or posters or books in movies. But the request this time was different: could we urgently help make … Continue reading “Quick, How Might the Alien Spacecraft Work?”
New U.S. “Roadmap” Lays Out Routes to Accelerate Robotic Technologies
Robotics technology is progressing faster than expected for self-driving cars, and drones are becoming ubiquitous throughout the United States, according to a lead scientist overseeing a robotics technology roadmap released last week. But robotics is moving slower than expected in some key areas, such as the development of dexterous gripper technology, intuitive user interfaces, and … Continue reading “New U.S. “Roadmap” Lays Out Routes to Accelerate Robotic Technologies”
Metacrine Receives $25,616,649 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9c754bfe-81cf-4dae-945a-3d6caeafc865 Date 11/10/2016 Company Name Metacrine Mailing Address 12780 El Camino Real San Diego, CA 92130 USA Company Description Metacrine is a biotech company founded in 2015 on technology licensed from the laboratory of Dr. Ronald Evans, a world leader in nuclear hormone receptors and Howard Hughes Medical Institute Investigator at the … Continue reading “Metacrine Receives $25,616,649 New Round”
Has Technology Made Election Polls More Accurate? Not Yet
Statistical models, simulations, social media outreach, and the capacity to analyze big data sets—you’d think by now that technology would have delivered election forecasts that more reliably predicted Donald Trump’s victory in the 2016 presidential race. But most pollsters—and the people who relied on them—were gobsmacked by Trump’s upset wins, not only in battleground states … Continue reading “Has Technology Made Election Polls More Accurate? Not Yet”
Trump’s Election Stunner: Tech and Life Sciences Leaders React
Still processing what this will mean for technology, business, society, and humanity—I guess it’s going to take a while. In the meantime, here are 10 notable reactions from around the Xconomy network, mostly via Twitter. As you might guess, they are a mix of outrage, resiliency, hope, rationalizing, grandstanding, and some calls for calm and … Continue reading “Trump’s Election Stunner: Tech and Life Sciences Leaders React”
In Trump-GOP Tsunami, Blue-State Healthcare Ideas Swamped
[Updated, 11/9/16, 1:20 p.m. See below.] The 2016 U.S. election is over. The country has been rocked by the presidential race, with Donald Trump taking the White House. Every facet of American policy, our attitudes toward power and governance, even our national character will be topics of debate in coming months. Our healthcare system will … Continue reading “In Trump-GOP Tsunami, Blue-State Healthcare Ideas Swamped”
Forecast Update: CA’s Prop. 61 Now A Toss-Up, New Poll Shows
Xconomy reported Thursday that support for Proposition 61, the California initiative to rein in drug prices, had slipped in a recent poll to a slim 51 percent majority, with 24 percent opposed and 25 percent undecided. Since then, a new state poll from a different pollster has put Prop. 61’s chances at a toss-up: 47 … Continue reading “Forecast Update: CA’s Prop. 61 Now A Toss-Up, New Poll Shows”
The Five Major Tech Trends of 2016
As we draw closer to the end of 2016, it is important that we take a moment to look back and reflect on all of the ways technology has inspired us, and transformed the way we live and do work. As technology becomes more pervasive in our lives, we increasingly look for simple but secure, … Continue reading “The Five Major Tech Trends of 2016”
New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease
Up until this point, studies of an experimental drug from Biogen and Ionis Pharmaceuticals had focused on patients with the most severe form of a rare, potentially deadly genetic disorder called spinal muscular atrophy. But new data released this morning show that the therapy, known as nusinersen (Spinraza), could have a much broader reach. Biogen … Continue reading “New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease”